October 2022
Maria Florez, MA
18th Clinical Trials Innovation Programme
Boston, MA | October 26-27
The Impact of Decentralized Trials on Sponsor-CRO Collaborations
Mary Jo Lamberti, PhD
Outsourcing in Clinical Trials New England
Boston, MA | October 12-13
Maria Florez, MA
Scope Europe
Barcelona | October 3-4
Characterizing the Innovation Adoption Cycle for Innovations Supporting Virtual Clinical Trials
Maria Florez, MA
Scope Europe
Barcelona | October 3-4
July 2022
Clinical Research Professionals and the Shift to Remote Work During the COVID-19 Pandemic
Maria Florez, MA and Mary Jo Lamberti, PhD
Clinical Operations in Oncology East Coast
Boston, MA | July 12-13
June 2022
Ensuring Diversity in Clinical Trials
Maria Florez, MA
DIA Global 2022
Chicago, IL | June 23
Optimizing the Pharma Workforce for Trial Success in the Digital Era
Maria Florez, MA
DIA Global 2022
Chicago, IL | June 23
Where Are We? Assessing Organizational Preparedness and Capabilities to Support Patient Engagement
Jennifer Kim, PhD
DIA Global 2022
Chicago, IL | June 21
Approaching the Assessment of Clinical Protocol Complexity
Zak Smith, MA; Denise Messer
DIA Annual Meeting
Chicago, IL | June 21
Quantifying Return on DCT Investment
Ken Getz, MBA
DIA Annual Meeting - Innovation Theater
Chicago, IL | June 21
Keynote Diamond Panel Discussion: The Future of Healthcare
Ken Getz, MBA
DIA Annual Meeting
Chicago, IL | June 20
State of the Drug Development Industry
Ken Getz, MBA
WCG
Webinar | June 15
COVID-19 Clinical Development Lessons Learned
Ken Getz, MBA
IQVIA Institute
Webinar | June 7
May 2022
Protocol Simplification and Optimization
Ken Getz, MBA
French AMMIS
Online | May 24
Characterizing the Innovation Adoption Process for Technologies Supporting Virtual Clinical Trials
Maria Florez, MA
Virtual Clinical Trials Summit
Philadelphia | May 18 - 19
Maria Florez, MA
18th Clinical Trials Innovation Programme
Boston, MA | May 17
April 2022
Signature Series: Fostering Diversity and Inclusion in Clinical Research
Maria Florez, MA
ACRP 2022
Orlando, FL | April 24
Joseph DiMasi, PhD
3rd International Phase-0/Microdosing Stakeholder Meeting
The Netherlands | April 22
Patient Engagement and the Deployment of DTC
Ken Getz, MBA
DTC National
Live | April 20
Assessing the Adoption of Innovations Supporting Drug Development Operations
Ken Getz, MBA
R&D Leadership Summit, The Conference Forum
Aventura, FL | April 11
State of the Drug Development Industry
Ken Getz, MBA
Chief Medical Officers Summit, The Conference Forum
Boston, MA | April 4
March 2022
Characterizing the Environment for Global Clinical Trials
Ken Getz, MBA
Brandeis University Business of Biotech Program
Online | March 1
Translational Science Education Roundtable
Ken Getz, MBA
National Center for Advancing Translational Science (NCATS), NIH, DHHS
Online | March 10
Jennifer Kim, PhD
DIA Patient Advisory Council
Online | March 28
Maria Florez, MA
DIA Europe 2022
Brussels, Belgium | March 31
Enhancing Patient Engagement: Emerging Research and Recommendations
Maria Florez, MA
DIA Europe 2022
Brussels, Belgium | March 31
February 2022
Measuring and Anticipating Patient Participation Burden in Clinical Trials
Ken Getz, MBA
SCOPE Summit
Online | February 9
Assessing Patient Enrollment Diversity in Clinical Trials
Zak Smith, MA; Emily Botto, BA; Ken Getz MBA
Finch Therapeutics Virtual Lunch & Learn
Online | February 4
Protocol Complexity in Oncology
Ken Getz, MBA
Online | February 2
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
Measuring eClinical Data Challenges and Performance
Zachary Smith, MA
Arena International
Online | June 2
Ken Getz, MBA
IQVIA Institute
Online | June 11
Common Pitfalls that Cause Clinical Trial Delays and How to Avoid Them
Ken Getz, MBA
CenterWatch webinar
Online | June 17
Enhancing Patient Participation Burden Assessment
Ken Getz, MBA
ZS Impact Webinar
Online | June 23
Impact of COVID-19 on Clinical Trial Execution
Mary Jo Lamberti, PhD
DIA Annual Meeting
Online | June 27 - July 1
May 2021
Drug Development Pain Points and Challenges
Ken Getz, MBA
BIO NJ Clinical Development Briefing
Online | May 27
The Evolving State of Clinical Trial Execution: Pilots or Permanent Change?
Ken Getz, MBA
ACRP Annual Meeting
Online | May 20
Ken Getz, MBA
RBQM Live
Online | May 20
Characterizing the Future of Clinical Trials
Ken Getz, MBA
Portland Clinical Research Professionals Northwest Association for Biomedical Research
Online | May 5
April 2021
Examining Strategic Implications of Pandemic Response on the Global Investigative Site Landscape
Ken Getz, MBA
SCRS EU Summit
Online | April 22
New Strategies to Balance Protocol Complexity, Customization, and Executional Feasibility
Ken Getz, MBA
Reuters Pharma: Clinical 2021
Online | April 7
March 2021
Michael Wilkinson, MPH, Zak Smith, MS, Ken Getz MBA
MCC Study Quality Trailblazer Group Meeting
Online | March 10
Anticipating Changes in Clinical Trial Design and Execution Post Pandemic
Ken Getz, MBA
Clinical Development and Innovation Forum 2021
Online | March 9
Accelerating Drug Development During the Pandemic - Lessons Learned and Their Implications
Ken Getz, MBA
SCOPE Virtual Summit for Clinical Ops Executives
Online | March 2
February 2021
Predictive Dosing to Reduce Clinical Trial Risk
Ken Getz, MBA
xTalks
Online | February 10
January 2021
Leveraging Patient and Participant Input to Optimize Protocol Design
Ken Getz, MBA
Trial Innovation Network
Online | January 4